Mindfulness-Based Stress Reduction To Improve Cognitive Function During Aromatase Inhibitor Therapy
Improving Brain Health During Breast Cancer Therapy
Status: Currently recruiting subjects.
Brief Description: If you are a postmenopausal woman who was diagnosed with breast cancer, you may qualify for this research study. The purpose of this study is to learn whether Mindfulness-Based Stress Reduction or a Health Enhancement Program improves cognitive function (your ability to concentrate and remember things) for women who take aromatase inhibitors. This study will evaluate cognitive function using a brain imaging technique called Magnetic Resonance Imaging (MRI), cognitive tests, and questionnaires. You will be paid up to $250 for completing the study.
1. Have gone through menopause (are postmenopausal)
2. Are younger than 80 years of age
3. Are diagnosed with stage 0 (DCIS) or stage 1, 2, or 3 breast cancer
4. Are taking an aromatase inhibitor or will be starting it soon
1. No stage IV (metastatic) breast cancer
2. Not claustrophobic (afraid of being in an MRI machine)
3. No major psychiatric disorder (schizophrenia, bipolar I disorder); no neurological disorder (Parkinson's Disease, dementia); and no head trauma.
Interested in participating?
If you, a family member, or someone you know is interested in this study, please contact our clinical research coordinator Makeda Brown at 212-998-9202 or firstname.lastname@example.org. Or, fill out our contact form. We will get back to you as soon as possible. Confidentiality will be maintained for all applicants and participants.